2Kerr DM, Fulton RL, Lees KR. Seven-Day NIHSS is a sensitive out-come measure for exploratory clinical trials in acute stroke: evi-dence from the virtual international stroke trials archive [J]. Stroke, 2012, 43(5): 1401-1403.
3Lee K R, Bluhmki E, Von KM, et al. Time to treatment with intravenous alteplase and outcom in Stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials [J]. Lancet, 2010, 375:1695-1703.
4Lyden P, Brott T. Improved reliability of the NIH Stroke Scale using video training. N1NDS tPA Stroke Study group [J]. Stroke, 1994, 25 (11): 2220-2226.
5Lloyd-Jones D, Adams R J, Brown TM et al. Heart disease and stroke statistics-2010 update: a report from the American HeartAssociation [J]. Circulation, 2010, 121 (7): 46-215.
6Jahan K, Duckwiler GR, Kidwell CS, et al. lntraarterial thrombolysis for treatment of acute stroke: experience in 26 patients with long term follow up[J]. AJNR, 1999, 20(7): 1291-1291.
7Glotta J C, Welch KMA, Fagan S C, et al .Clinical deteriorati on following improvement in the NINDS rt-PA stroke trial [J]. Stroke, 2001, 32(3): 661-668.
8Tveit A, BoUmann A, Seljeflot I, et al. Relation between atrial fibrillatory rate and markers ofinflammation and haemostasis in persistent human atrial fibrillation[J]. Thromb, 2009, 101(3): 601-603.
9Chesebro J H, Knatterud G, Roberts R, et al. Throblysis in Myocardial In-farction (TIMI) Tria, l Phase 1: A comparison bet ween intravenous tissueplas m inogen activator and intravenous streptokinase [J]. Clinical findings through hospital discharge. Circulation, 1987, 176(1): 142-154.
10Marder VI, Sherry S. Thrombolitic therapy [J]. Current status N ew Eng 1 JMed, 1988, 318:1512-1515.
